Global conference to focus on advancing the transformative impacts of genomic health SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company’s global event focused […]
Porvair Sciences has introduced a 96-well deep well microplate designed for labs using magnetic beads for nucleic acid purification, clean up and protein purifications. The 96-well magnetic bead separation plate has a reinforced base that can be routinely centrifuged at up to 6,000x g enabling faster magnetic bead separation protocols and improved sample quality. Manufactured in […]
The Science Based Targets initiative has validated Illumina’s targets to reach Net-Zero greenhouse gas emissions by 2050 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). […]
PLEASANTON, Calif. — Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the hiring of Jim Wilbur, Ph.D., as Chief Commercial Officer, effective July 27. In this role, Wilbur will be responsible for driving commercial strategy and execution and leading the company’s sales, support and marketing functions. A life sciences entrepreneur and seasoned […]
Expands bioanalytical services to include many emerging areas worldwide MALVERN, Pa. – Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital Partners, a global healthcare […]
Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems MOUNTAIN VIEW, Calif. & SOUTH SAN FRANCISCO, Calif. — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, and Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through […]
Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology ALBUQUERQUE, N.M. — BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced that experienced and […]
Fast, flexible and easy-to-use qScript Ultra Flex Kit and qScript Ultra SuperMix enable scientists to reverse transcribe longer targets and maximize yields from challenging samples in only 10 minutes BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced […]
NEWARK, Calif. — Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance Ultima Genomics’ sequencing architecture. Under the terms of the agreement, Regeneron will collaborate with Ultima on the development and testing of Ultima’s second-generation sequencing platform, which will build upon the advances of the Company’s first […]
Oxford, UK – OGT, A Sysmex Group Company, announces that it is rapidly increasing its international reach – benefitting more regions with access to the company’s renowned clinical genomics solutions, expertise and technical support network. OGT has been working closely with Sysmex group companies and new distributors to achieve this, and all new and existing […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
